Management of ureteral and renal pelvic recurrence after cystectomy

K. G. Braslis, M. S. Soloway

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Relatively few data are available on UT TCC following cystectomy. In most circumstances nephroureterectomy is the treatment of choice. The risk of bilateral disease is small (2% to 4%); however, in patients with bilateral UT TCC, a solitary kidney, or poor renal function and low-stage, low-grade TCC, renal preservation by local resection and/or topical therapy may be effective. In high-grade or high-stage disease, whenever feasible nephroureterectomy should be performed.

Original languageEnglish
Pages (from-to)653-659
Number of pages7
JournalUrologic Clinics of North America
Volume21
Issue number4
StatePublished - Jan 1 1994

Fingerprint

Cystectomy
Kidney
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Management of ureteral and renal pelvic recurrence after cystectomy. / Braslis, K. G.; Soloway, M. S.

In: Urologic Clinics of North America, Vol. 21, No. 4, 01.01.1994, p. 653-659.

Research output: Contribution to journalArticle

Braslis, K. G. ; Soloway, M. S. / Management of ureteral and renal pelvic recurrence after cystectomy. In: Urologic Clinics of North America. 1994 ; Vol. 21, No. 4. pp. 653-659.
@article{9795e9ebabbb46b19efaaed52a4abdc0,
title = "Management of ureteral and renal pelvic recurrence after cystectomy",
abstract = "Relatively few data are available on UT TCC following cystectomy. In most circumstances nephroureterectomy is the treatment of choice. The risk of bilateral disease is small (2{\%} to 4{\%}); however, in patients with bilateral UT TCC, a solitary kidney, or poor renal function and low-stage, low-grade TCC, renal preservation by local resection and/or topical therapy may be effective. In high-grade or high-stage disease, whenever feasible nephroureterectomy should be performed.",
author = "Braslis, {K. G.} and Soloway, {M. S.}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "21",
pages = "653--659",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Management of ureteral and renal pelvic recurrence after cystectomy

AU - Braslis, K. G.

AU - Soloway, M. S.

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Relatively few data are available on UT TCC following cystectomy. In most circumstances nephroureterectomy is the treatment of choice. The risk of bilateral disease is small (2% to 4%); however, in patients with bilateral UT TCC, a solitary kidney, or poor renal function and low-stage, low-grade TCC, renal preservation by local resection and/or topical therapy may be effective. In high-grade or high-stage disease, whenever feasible nephroureterectomy should be performed.

AB - Relatively few data are available on UT TCC following cystectomy. In most circumstances nephroureterectomy is the treatment of choice. The risk of bilateral disease is small (2% to 4%); however, in patients with bilateral UT TCC, a solitary kidney, or poor renal function and low-stage, low-grade TCC, renal preservation by local resection and/or topical therapy may be effective. In high-grade or high-stage disease, whenever feasible nephroureterectomy should be performed.

UR - http://www.scopus.com/inward/record.url?scp=0028063633&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028063633&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 653

EP - 659

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 4

ER -